Metropolitan Digital

Men's Weekly


.

China's win-at-all-costs approach suggests it will follow its own dangerous path in biomedicine

  • Written by Hallam Stevens, Associate Professor of History, Nanyang Technological University
China's win-at-all-costs approach suggests it will follow its own dangerous path in biomedicineMegacity Shenzhen, as seen from Hong Kong, is a center for Chinese finance and tech.AP Photo/Kin Cheung

The world was shocked by Chinese scientist He Jiankui’s recent claim that he’d brought to term twin babies whose genes – inheritable by their own potential descendants – he had modified as embryos. The genetic edit, He...

Read more: China's win-at-all-costs approach suggests it will follow its own dangerous path in biomedicine

More Articles ...

  1. Why the Texas ruling on Obamacare is on shaky legal ground
  2. Can your heart grow three sizes? A doctor reads 'How the Grinch Stole Christmas'
  3. Is the FDA being Grinch-like in raising concerns about raw cookie dough?
  4. Cómo alentar a las niñas a estudiar carreras científicas y matemáticas: 7 estrategias
  5. As hunting declines, efforts grow to broaden the funding base for wildlife conservation
  6. What the US could learn from Thailand about health care coverage
  7. Trump administration ban on NIH use of fetal tissue should worry all scientists
  8. The NRA's financial weakness, explained
  9. Nearly all sexual harassment at work goes unreported – and those who do report often see zero benefit
  10. We train Colombian woolly monkeys to be wild again – and maybe save them from extinction
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more